Breeze Medical
Breeze Medical
South Korea has emerged as a global powerhouse in the biotechnology sector, with massive investments in "K-Bio" clusters in Incheon (Songdo) and Osong. This has driven an unprecedented demand for high-quality Serological Pipettes and Biohazard Specimen Bags.
Current trends in Korea focus on automation and high-purity production. Manufacturers are shifting towards 100,000-grade cleanroom environments to ensure that every pipette is non-pyrogenic, non-cytotoxic, and free of DNase/RNase.
As a leading Biohazard Specimen Bags Manufacturer & Exporter in Korea, Ningbo Breeze Medical leverages its 10+ years of expertise to supply the demanding Korean market. In Korea, serological pipettes are not just simple tools; they are critical components in the mass production of biopharmaceuticals and cell culture research conducted by industry giants like Samsung Biologics and Celltrion.
The local application scenarios include high-throughput screening, diagnostic kit development, and vaccine production. Korean laboratories prioritize ergonomic design and high graduation accuracy, ensuring that liquid transfers are precise down to the microliter.
Ningbo Breeze Medical Co., Ltd., founded in 2011, has established itself as a leader in the medical device industry, specializing in the manufacturing of disposable medical consumables and laboratory instruments. Committed to providing the highest quality products, the company has invested in state-of-the-art infrastructure, including a cleanroom, an automatic injection molding workshop, and a support production line that meets the strictest GMP (Good Manufacturing Practice) standards.
The company has set up a Product Quality Testing Center to ensure the reliability and performance of all its products, particularly for the sensitive requirements of the Korean pharmaceutical export market.
In the bustling research districts of Pangyo and Daedeok Innopolis, our Serological Pipettes are utilized in advanced genomic sequencing and protein purification workflows. The Korean market demands strict adherence to international safety protocols, making our Biohazard Specimen Bags the preferred choice for hospitals in Seoul for the safe transport of infectious substances.
The industry trend in Korea is currently shifting towards "Smart Labs," where consumables must be compatible with automated liquid handling robots. Our products are designed with this compatibility in mind, featuring consistent dimensions and high-clarity polystyrene for optical sensor detection.
Daily use in clinical diagnostics and specimen collection across major Korean university hospitals.
Supporting high-level academic research at KAIST and Seoul National University.
Ningbo Breeze Medical is certified with the highest international standards, including CE, ISO 13485, and ISO 9001. These certifications are a prerequisite for entering the competitive South Korean medical market and serve as a testament to our commitment to global safety regulations.
Scientific research is a key pillar of Breeze Medical’s innovation. The company continuously invests in developing new technologies and products that contribute to improved healthcare. Additionally, it boasts a team of highly skilled technical support engineers who provide 24/7 assistance to address any customer inquiries or needs, ensuring professional and timely service at all times.
As we look to the future, Ningbo Breeze Medical Co., Ltd. continues to move forward with a strong focus on quality, innovation, and global expansion, offering effective and reliable solutions for the medical and laboratory sectors across South Korea and the rest of the world.
Exporting to major markets in North America, Europe, and Asia, maintaining high brand trust.
Full compliance with MFDS (Korea) and FDA regulations for medical consumables.
Additional products available for the Korean market include:
